These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

443 related articles for article (PubMed ID: 34105856)

  • 21. Risk of coronavirus disease 2019 hospitalization and mortality in rheumatic patients treated with hydroxychloroquine or other conventional disease-modifying anti-rheumatic drugs in Italy.
    Spila Alegiani S; Crisafulli S; Giorgi Rossi P; Mancuso P; Salvarani C; Atzeni F; Gini R; Kirchmayer U; Belleudi V; Kurotschka PK; Leoni O; Ludergnani M; Ferroni E; Baracco S; Massari M; Trifirò G;
    Rheumatology (Oxford); 2021 Oct; 60(SI):SI25-SI36. PubMed ID: 33856453
    [TBL] [Abstract][Full Text] [Related]  

  • 22. COVID-19: a primer for the rheumatologist: management of patients and care settings.
    Calabrese C; Lehman B
    Curr Opin Rheumatol; 2020 Sep; 32(5):429-433. PubMed ID: 32744823
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The influence of the SARS-CoV-2 lockdown on patients with inflammatory rheumatic diseases on their adherence to immunomodulatory medication: a cross sectional study over 3 months in Germany.
    Hasseli R; Müller-Ladner U; Keil F; Broll M; Dormann A; Fräbel C; Hermann W; Heinmüller CJ; Hoyer BF; Löffler F; Özden F; Pfeiffer U; Saech J; Schneidereit T; Schlesinger A; Schwarting A; Specker C; Stapfer G; Steinmüller M; Storck-Müller K; Strunk J; Thiele A; Triantafyllias K; Vagedes D; Wassenberg S; Wilden E; Zeglam S; Schmeiser T
    Rheumatology (Oxford); 2021 Oct; 60(SI):SI51-SI58. PubMed ID: 33704418
    [TBL] [Abstract][Full Text] [Related]  

  • 24. American College of Rheumatology Guidance for the Management of Rheumatic Disease in Adult Patients During the COVID-19 Pandemic: Version 1.
    Mikuls TR; Johnson SR; Fraenkel L; Arasaratnam RJ; Baden LR; Bermas BL; Chatham W; Cohen S; Costenbader K; Gravallese EM; Kalil AC; Weinblatt ME; Winthrop K; Mudano AS; Turner A; Saag KG
    Arthritis Rheumatol; 2020 Aug; 72(8):1241-1251. PubMed ID: 32349183
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Updated APLAR consensus statements on care for patients with rheumatic diseases during the COVID-19 pandemic.
    Tam LS; Tanaka Y; Handa R; Li Z; Lorenzo JP; Louthrenoo W; Hill C; Pile K; Robinson PC; Dans LF; Hsu LY; Lee SM; Cho J; Hasan ATMT; Salim B; Samreen S; Shaharir SS; Wong P; Chau J; Danda D; Haq SA
    Int J Rheum Dis; 2021 Jun; 24(6):733-745. PubMed ID: 33945214
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Factors associated with COVID-19-related death in people with rheumatic diseases: results from the COVID-19 Global Rheumatology Alliance physician-reported registry.
    Strangfeld A; Schäfer M; Gianfrancesco MA; Lawson-Tovey S; Liew JW; Ljung L; Mateus EF; Richez C; Santos MJ; Schmajuk G; Scirè CA; Sirotich E; Sparks JA; Sufka P; Thomas T; Trupin L; Wallace ZS; Al-Adely S; Bachiller-Corral J; Bhana S; Cacoub P; Carmona L; Costello R; Costello W; Gossec L; Grainger R; Hachulla E; Hasseli R; Hausmann JS; Hyrich KL; Izadi Z; Jacobsohn L; Katz P; Kearsley-Fleet L; Robinson PC; Yazdany J; Machado PM;
    Ann Rheum Dis; 2021 Jul; 80(7):930-942. PubMed ID: 33504483
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [A cross sectional study on patients with inflammatory rheumatic diseases in terms of their compliance to their immunsuppressive medication during COVID-19 pandemic].
    Schmeiser T; Broll M; Dormann A; Fräbel C; Hermann W; Hudowenz O; Keil F; Müller-Ladner U; Özden F; Pfeiffer U; Saech J; Schwarting A; Stapfer G; Steinchen N; Storck-Müller K; Strunk J; Thiele A; Triantafyllias K; Wassenberg S; Wilden E; Hasseli R
    Z Rheumatol; 2020 May; 79(4):379-384. PubMed ID: 32303821
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Influence of COVID-19 pandemic on decisions for the management of people with inflammatory rheumatic and musculoskeletal diseases: a survey among EULAR countries.
    Dejaco C; Alunno A; Bijlsma JW; Boonen A; Combe B; Finckh A; Machado PM; Padjen I; Sivera F; Stamm TA; Buttgereit F
    Ann Rheum Dis; 2021 Apr; 80(4):518-526. PubMed ID: 33158877
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Patients with Rheumatic Diseases Overlooked during COVID-19 Pandemic: How are They Doing and Behaving?
    Adnine A; Soussan I; Nadiri K; Coulibaly S; Berrada K; Najdi A; Abourazzak FE
    Curr Rheumatol Rev; 2021 Aug; 17(3):318-326. PubMed ID: 33371850
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Influence of the COVID-19 Pandemic on Medical Management and on Healthcare Delivery of Immune-Mediated Rheumatic and Musculoskeletal Diseases during the First Pandemic Period February to July 2020: A Systematic Review.
    Schlegel M; Bachmann S
    Medicina (Kaunas); 2024 Apr; 60(4):. PubMed ID: 38674242
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Incidence and severeness of COVID-19 hospitalization in patients with inflammatory rheumatic disease: a nationwide cohort study from Denmark.
    Cordtz R; Lindhardsen J; Soussi BG; Vela J; Uhrenholt L; Westermann R; Kristensen S; Nielsen H; Torp-Pedersen C; Dreyer L
    Rheumatology (Oxford); 2021 Oct; 60(SI):SI59-SI67. PubMed ID: 33369663
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Role of targeted therapies in rheumatic patients on COVID-19 outcomes: results from the COVIDSER study.
    Álvaro Gracia JM; Sanchez-Piedra C; Manero J; Ruiz-Lucea ME; López-Vives L; Bohorquez C; Martinez-Barrio J; Bonilla G; Vela P; García-Villanueva MJ; Navío-Marco MT; Pavía M; Galindo M; Erausquin C; Gonzalez-Gay MA; Rua-Figueroa I; Pego-Reigosa JM; Castrejon I; Sanchez-Costa JT; González-Dávila E; Diaz-Gonzalez F;
    RMD Open; 2021 Dec; 7(3):. PubMed ID: 34887346
    [TBL] [Abstract][Full Text] [Related]  

  • 33. COVID-19 and autoimmune rheumatic disease: behavioural changes adopted by patients amid the pandemic.
    Dey D; Katso B; Issaka S; Adjei P
    Intern Med J; 2024 Aug; 54(8):1376-1383. PubMed ID: 38816941
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Rheumatologic Aspects of the COVID-19 Pandemic: A Practical Resource for Physicians in Kuwait and the Gulf region as Recommended by the Kuwait Association of Rheumatology.
    Baron F; Alhajeri H; Abutiban F; Almutairi M; Alawadhi A; Aldei A; Alherz A; Ali Y; Alsayegh S; Dehrab A; Ghanem A; Hajji E; Hayat S; Saleh K; Shaikh-Alsooq R; Tarakmah H; Albasri A; Alenezi A; Alhadhood N; Alkanderi W; Almathkoori A; Almutairi N; Alturki A; Alkadi A; Behbahani H
    Curr Rheumatol Rev; 2022; 18(2):108-116. PubMed ID: 34620059
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Impact of COVID-19 on patients with rheumatic complications of cancer immunotherapy: results of a registry survey.
    Ghosh N; Tirpack A; Chan KK; Bass AR
    J Immunother Cancer; 2020 Oct; 8(2):. PubMed ID: 33067320
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The conundrum of COVID-19 treatment targets: the close correlation with rheumatology. Response to: 'Management of rheumatic diseases in the time of covid-19 pandemic: perspectives of rheumatology pracitioners from India' by Gupta
    Monti S; Montecucco C
    Ann Rheum Dis; 2021 Jan; 80(1):e3. PubMed ID: 32340978
    [No Abstract]   [Full Text] [Related]  

  • 37. Risk of severe COVID-19 in patients with inflammatory rheumatic diseases treated with immunosuppressive therapy in Scotland.
    McKeigue PM; Porter D; Hollick RJ; Ralston SH; McAllister DA; Colhoun HM
    Scand J Rheumatol; 2023 Jul; 52(4):412-417. PubMed ID: 35549809
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The impact of the ongoing COVID-19 pandemic on the management of rheumatic disease: a national clinician-based survey.
    Kahveci A; Gümüştepe A; Güven N; Ataman Ş
    Rheumatol Int; 2022 Apr; 42(4):601-608. PubMed ID: 35165770
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Perspectives of Patients With Rheumatic Diseases in the Early Phase of COVID-19.
    Antony A; Connelly K; De Silva T; Eades L; Tillett W; Ayoub S; Morand E
    Arthritis Care Res (Hoboken); 2020 Sep; 72(9):1189-1195. PubMed ID: 32526068
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Updated recommendations of the German Society for Rheumatology for the care of patients with inflammatory rheumatic diseases in times of SARS-CoV-2-methodology, key messages and justifying information.
    Schulze-Koops H; Krüger K; Hoyer BF; Leipe J; Iking-Konert C; Specker C;
    Rheumatology (Oxford); 2021 May; 60(5):2128-2133. PubMed ID: 33502500
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 23.